![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/spacer.gif)
| Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Bloquea las enzimas que reparan el daño que la quimioterapia y la radioterapia causan al ADN. El inhibidor de PARP-1 AG014699 es un tipo de inhibidor de la poli (ADP-ribosa) polimerasa. También se llama AG014699. |
![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090116040130im_/http://www.cancer.gov/images/spacer.gif) |